000 01574 a2200361 4500
005 20250517122456.0
264 0 _c20180404
008 201804s 0 0 eng d
022 _a1600-0714
024 7 _a10.1111/jop.12516
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHernandez, Magali
245 0 0 _aUse of new targeted cancer therapies in children: effects on dental development and risk of jaw osteonecrosis: a review.
_h[electronic resource]
260 _bJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
_cMay 2017
300 _a321-326 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntinematodal Agents
_xadverse effects
650 0 4 _aBevacizumab
_xadverse effects
650 0 4 _aBisphosphonate-Associated Osteonecrosis of the Jaw
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDenosumab
_xadverse effects
650 0 4 _aDiphosphonates
_xadverse effects
650 0 4 _aHumans
650 0 4 _aTooth
_xdrug effects
650 0 4 _aTooth Eruption
_xdrug effects
700 1 _aPhulpin, Bérengère
700 1 _aMansuy, Ludovic
700 1 _aDroz, Dominique
773 0 _tJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
_gvol. 46
_gno. 5
_gp. 321-326
856 4 0 _uhttps://doi.org/10.1111/jop.12516
_zAvailable from publisher's website
999 _c26547648
_d26547648